Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I G Robertson

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1992
Intraperitoneal administration of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in the mouse: bioavailability, pharmacokinetics and toxicity after a single doseS M Evans, D Young, I G Robertson, et al.
Drug Metabolism and Drug Interactions|January 1, 1988
Involvement of glutathione in the metabolism of the anilinoacridine antitumour agents CI-921 and amsacrineI G Robertson, P Kestell, R A Dormer, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1993
Rat hepatocyte-mediated metabolism of the experimental anti-tumour agent N-[2'-(dimethylamino)ethyl]acridine-4-carboxamideB Schlemper, D J Siegers, J W Paxton, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 1, 1992
Differences in the metabolism of the antitumour agents amsacrine and its derivative CI-921 in rat and mouseI G Robertson, B D Palmer, J W Paxton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1993
Metabolism of the experimental antitumor agent acridine carboxamide in the mouseI G Robertson, B D Palmer, J W Paxton, et al.
Molecular Pharmacology|July 1, 1983
The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbitalI G Robertson, C Serabjit-Singh, J E Croft, et al.
The Journal of Biological Chemistry|November 10, 1983
Interactions between xenobiotics that increase or decrease the levels of cytochrome P-450 isozymes in rabbit lung and liverC J Serabjit-Singh, P W Albro, I G Robertson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Tumour profile of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide after intraperitoneal administration in the mouseJ W Paxton, D Young, S M Evans, et al.
Cancer Research|May 1, 1982
Selective activation of some dihydrodiols of several polycyclic aromatic hydrocarbons to mutagenic products by prostaglandin synthetaseJ Guthrie, I G Robertson, E Zeiger, et al.
Cancer Letters|April 1, 1989
Differences in detection of DNA adducts in the 32P-postlabelling assay after either 1-butanol extraction or nuclease P1 treatmentJ E Gallagher, M A Jackson, M H George, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|January 1, 1992
Intraperitoneal administration of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in the mouse: bioavailability, pharmacokinetics and toxicity after a single doseS M Evans, D Young, I G Robertson, et al.
Drug Metabolism and Drug Interactions|January 1, 1988
Involvement of glutathione in the metabolism of the anilinoacridine antitumour agents CI-921 and amsacrineI G Robertson, P Kestell, R A Dormer, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1993
Rat hepatocyte-mediated metabolism of the experimental anti-tumour agent N-[2'-(dimethylamino)ethyl]acridine-4-carboxamideB Schlemper, D J Siegers, J W Paxton, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 1, 1992
Differences in the metabolism of the antitumour agents amsacrine and its derivative CI-921 in rat and mouseI G Robertson, B D Palmer, J W Paxton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1993
Metabolism of the experimental antitumor agent acridine carboxamide in the mouseI G Robertson, B D Palmer, J W Paxton, et al.
Molecular Pharmacology|July 1, 1983
The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbitalI G Robertson, C Serabjit-Singh, J E Croft, et al.
The Journal of Biological Chemistry|November 10, 1983
Interactions between xenobiotics that increase or decrease the levels of cytochrome P-450 isozymes in rabbit lung and liverC J Serabjit-Singh, P W Albro, I G Robertson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Tumour profile of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide after intraperitoneal administration in the mouseJ W Paxton, D Young, S M Evans, et al.
Cancer Research|May 1, 1982
Selective activation of some dihydrodiols of several polycyclic aromatic hydrocarbons to mutagenic products by prostaglandin synthetaseJ Guthrie, I G Robertson, E Zeiger, et al.
Cancer Letters|April 1, 1989
Differences in detection of DNA adducts in the 32P-postlabelling assay after either 1-butanol extraction or nuclease P1 treatmentJ E Gallagher, M A Jackson, M H George, et al.
Pageof 4